1. Home
  2. LUNG vs MQT Comparison

LUNG vs MQT Comparison

Compare LUNG & MQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • MQT
  • Stock Information
  • Founded
  • LUNG 1995
  • MQT 1992
  • Country
  • LUNG United States
  • MQT United States
  • Employees
  • LUNG N/A
  • MQT N/A
  • Industry
  • LUNG Industrial Specialties
  • MQT Investment Bankers/Brokers/Service
  • Sector
  • LUNG Health Care
  • MQT Finance
  • Exchange
  • LUNG Nasdaq
  • MQT Nasdaq
  • Market Cap
  • LUNG 251.5M
  • MQT 234.8M
  • IPO Year
  • LUNG 2020
  • MQT N/A
  • Fundamental
  • Price
  • LUNG $6.23
  • MQT $10.00
  • Analyst Decision
  • LUNG Buy
  • MQT
  • Analyst Count
  • LUNG 6
  • MQT 0
  • Target Price
  • LUNG $11.92
  • MQT N/A
  • AVG Volume (30 Days)
  • LUNG 242.6K
  • MQT 52.5K
  • Earning Date
  • LUNG 02-19-2025
  • MQT 01-01-0001
  • Dividend Yield
  • LUNG N/A
  • MQT 4.60%
  • EPS Growth
  • LUNG N/A
  • MQT N/A
  • EPS
  • LUNG N/A
  • MQT N/A
  • Revenue
  • LUNG $79,302,000.00
  • MQT N/A
  • Revenue This Year
  • LUNG $22.26
  • MQT N/A
  • Revenue Next Year
  • LUNG $18.72
  • MQT N/A
  • P/E Ratio
  • LUNG N/A
  • MQT N/A
  • Revenue Growth
  • LUNG 22.34
  • MQT N/A
  • 52 Week Low
  • LUNG $5.46
  • MQT $8.59
  • 52 Week High
  • LUNG $14.84
  • MQT $10.67
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 41.37
  • MQT 25.97
  • Support Level
  • LUNG $5.72
  • MQT $10.45
  • Resistance Level
  • LUNG $6.28
  • MQT $10.67
  • Average True Range (ATR)
  • LUNG 0.40
  • MQT 0.12
  • MACD
  • LUNG -0.03
  • MQT -0.06
  • Stochastic Oscillator
  • LUNG 19.85
  • MQT 5.33

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About MQT Blackrock MuniYield Quality Fund II Inc.

BLACKROCK MUNIYIELD QUALITY FUND II, INC. is a closed-end fund. Its objective is to provide shareholders with as high a level of current income exempt from federal income taxes as is consistent with its investment policies and prudent investment management. It invests in various sectors such as Transportation, Utilities, Health, County/City/Special District/School District, Education, Housing, Corporate, and Tobacco.

Share on Social Networks: